Recombinant Human LILRA1 protein (His Tag)

种属

Human

纯度

>90 %, SDS-PAGE

标签

His Tag

生物活性

未测试

Cat no : Eg4704

Print datasheet

Synonyms

CD85 antigen-like family member I, CD85i, Leukocyte immunoglobulin-like receptor 6, Leukocyte immunoglobulin-like receptor subfamily A member 1, LIR6



产品信息

纯度 >90 %, SDS-PAGE
内毒素 <0.1 EU/μg protein, LAL method
生物活性
Not tested
来源 HEK293-derived Human LILRA1 protein Pro17-Asn461 (Accession# O75019-1) with a His tag at the C-terminus.
基因ID 11024
蛋白编号 O75019-1
预测分子量 49.6 kDa
SDS-PAGE 60-75kDa, reducing (R) conditions
组分 Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
复溶 Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
储存条件
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
运输条件 The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

背景信息

Leukocyte immunoglobulin-like receptor A1 (LILRA1) plays a significant role in the immune system. It is part of the leukocyte immunoglobulin-like receptor (LIR) family. The LILRA1 is predominantly expressed in B cells, where it interacts with major histocompatibility complex class I ligands and contributes to the regulation of immune responses. LILRA1 is involved in various pathways, including the innate immune system and Class I MHC-mediated antigen processing and presentation. It is known to have multiple functions, such as acting as a receptor for class I MHC antigens and potentially playing a role in the recognition and modulation of immune responses.

参考文献:

1. Tedla N. et al. (2011). Tissue Antigens. 77(4):305–316. 2. Hogan LE. et al.(2016). Sci Rep. 6(1):21780. 3. Hirayasu K. et al. (2015). J Hum Genet. 60(11):703–708. 4. An H. et al. (2010). J Rheumatol.37(8):1596–1606.

||
New chat Able
正在加载,请稍候...